Justine R. Smith receives funding from Macular Disease Foundation Australia, Queensland Eye Institute Foundation, Flinders Foundation and the National Health and Medical Research Council of Australia.
Kodiak Sciences Inc. announced at the recent American Academy of Ophthalmology meetings that intraocular interleukin-6 inhibition in Phase 3 clinical trials delivered meaningful improvement in vision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback